Recurrent or Metastatic Nasopharyngeal Carcinom
1 clinical trials · Condition
◉ Watch Recurrent or Metastatic Nasopharyngeal Carcinom
| Record | Firm | Date |
|---|---|---|
| Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11 (NCT06440187) | Seoul National University Hospital | 2018-06-08 |
Track Recurrent or Metastatic Nasopharyngeal Carcinom automatically
Every clearance here is in the API, with alerts when new ones post.